How a strategic investment in technology transfers results in long-term cost savings.

Whether it’s for scaling-up or moving to another facility, technology transfers are part of the normal course of business. In 2019, we successfully completed 119 technology transfers—44 commercial, 60 drug substance, and 15 development. Our dedicated global experts ensure:

  • Process validation is in accordance with regulatory and cGMP guidelines
  • Speed and agility so your project stays on track and product supply is preserved
  • Seamless execution for right-the-first-time delivery
  • Access to a robust system to manage the product lifecycle
  • Insight to all stage gates required for each phase
  • Access to stability studies, analytical data, release testing, and other regulatory documentation

Download our whitepaper, “Technology Transfers: Reaping Rewards, Reducing Risks”.

関連する施設紹介

関連する各種資料